Habico Invest

To add a bio or update investment portfolio, please click update information.

Investment Portfolio

Allos AI raises £4m in a seed round led by Oxford Science Enterprises to reformulate complex small-molecule generic drugs

13 Jan 2026

Allos AI raises £4m in a seed round led by Oxford Science Enterprises to reformulate complex small-molecule generic drugs

Allos AI applies causal AI to reformulate complex generic drugs, improving delivery, tolerability and predictability while reducing development uncertainty.

Habico Invest

- Life Sciences
1(12 months)
habicoinvest.com
Update Information

More venture news

Crimson
29 May 2026
Crimson closes a £1.9m seed round led by Y Combinator to expand its case intelligence platform built for litigation and arbitration teams
SeedLegal
Perceptic
28 May 2026
Perceptic raises a £9m seed round led by Accel to unify drug discovery and development on a single AI platform
SeedLife Sciences
Zonova
26 May 2026
Zonova lands a £2.1m seed round from THENA Capital to prevent infection in medical devices
SeedHealth

Habico Invest

Investment Portfolio

Allos AI raises £4m in a seed round led by Oxford Science Enterprises to reformulate complex small-molecule generic drugs

More venture news

Crimson closes a £1.9m seed round led by Y Combinator to expand its case intelligence platform built for litigation and arbitration teams

Perceptic raises a £9m seed round led by Accel to unify drug discovery and development on a single AI platform

Zonova lands a £2.1m seed round from THENA Capital to prevent infection in medical devices